HBK Investments »

Cidara Therapeutics shares owned by HBK Investments

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by HBK Investments from 13F filings

Historical chart of HBK Investments investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by HBK Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by HBK Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $278M 1.3M 220.89

More positions owned by HBK Investments

NVIDIA Corporation Put Option (NVDA)
Cyberark Software SHS (CYBR)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
EXACT Sciences Corporation (EXAS)
Hologic (HOLX)
Norfolk Southern (NSC)
Ceridian Hcm Hldg
Confluent Class A Com (CFLT)
Chart Industries (GTLS)
Electronic Arts (EA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Comerica Incorporated
Avidity Biosciences Ord (RNA)
Warner Bros Discovery Com Ser A Call Option (WBD)
Frontier Communications Pare

View all positions for HBK Investments

Top funds holding Cidara Therapeutics

RA Capital Management
Vanguard Group
BlackRock
HBK Investments
Fil
UBS Group
Darwin Global Management
Vivo Capital
State Street Corporation
Susquehanna International
Leucadia National Corporation
Paradigm Biocapital Advisors
Balyasny Asset Management
Glazer Capital
Ikarian Capital

View all funds holding Cidara Therapeutics